🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for transformative discoveries that clarify how the immune system attacks dangerous infections while protecting the healthy tissues.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this accolade.

The work uncovered unique "security guards" within the immune system that eliminate malfunctioning immune cells that could harming the organism.

The discoveries are now enabling innovative treatments for autoimmune diseases and cancer.

The winners will share a monetary award worth 11m Swedish kronor.

Crucial Findings

"Their research has been essential for comprehending how the immune system operates and why we don't all develop serious self-attack conditions," commented the head of the award panel.

The team's research address a fundamental question: In what way does the defense system protect us from countless invaders while keeping our own tissues unharmed?

The immune system employs white blood cells that search for indicators of infection, even pathogens and germs it has not met before.

Such defenders utilize sensors—called recognition units—that are generated by chance in a vast number of combinations.

That provides the immune system the capacity to combat a broad range of threats, but the unpredictability of the mechanism inevitably produces white blood cells that can target the host.

Protectors of the Immune System

Researchers previously knew that some of these problematic defense cells were destroyed in the immune organ—where immune cells mature.

This year's Nobel Prize honors the identification of regulatory T-cells—known as the body's "security guards"—which travel through the system to neutralize other immune cells that assault the body's own tissues.

It is known that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

A Nobel panel added, "These discoveries have laid the foundation for a new field of investigation and accelerated the development of new therapies, for instance for tumors and autoimmune diseases."

Regarding malignancies, regulatory T-cells prevent the system from attacking the growth, so research are focused on lowering their numbers.

For self-attack disorders, trials are exploring boosting regulatory T-cells so the organism is not being harmed. A comparable approach could also be effective in minimizing the chances of organ transplant rejection.

Pioneering Experiments

Prof Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland removed, leading to self-attack conditions.

The researcher demonstrated that injecting immune cells from healthy animals could prevent the illness—suggesting there was a system for blocking immune cells from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at a biotech firm in San Francisco, were studying an genetic autoimmune disease in rodents and humans that resulted in the discovery of a gene critical for the way T-regs operate.

"The pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly targeting the body's own tissues," commented a prominent biological science expert.

"The work is a striking illustration of how basic biological study can have broad implications for human health."